Translational control is a pivotal mechanism in cancer progression55, hence future work investigating the detailed mechanism by which kindlin-3 regulates c-Myc protein translation could provide useful insights for the development of alternative strategies in treating CML. This evidence concerns the gene MYC and chronic myelogenous leukemia, BCR-ABL1 positive.